Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical HSCT with CD3 Depletion for Pediatric Acute Leukemia and MDS
NCT01509300Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, fludarabine, cyclophosphamide in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), solid tumor, sponsored by Asan Medical Center. Status: unknown.
02
Drugs
antithymocyte globulin rabbitfludarabinecyclophosphamide
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)solid tumor
Beyond the preview
Go deeper on NCT01509300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01509300.